Found: 1
Select item for more details and to access through your institution.
Randomized Placebo-Controlled and Controlled Non-Inferiority Phase III Trials Comparing Trafermin, a Recombinant Human Fibroblast Growth Factor 2, and Enamel Matrix Derivative in Periodontal Regeneration in Intrabony Defects.
- Published in:
- Journal of Bone & Mineral Research, 2016, v. 31, n. 4, p. 806, doi. 10.1002/jbmr.2738
- By:
- Publication type:
- Article